14.8  -0.17 (-1.14%)		11-11 16:00
Open: 14.73 High: 15.1 Volume: 18,834		Pre. Close: 14.97 Low: 14.73 Market Cap: 91(M)

Short term
Mid term
Targets	6-month :	18.09	1-year :	18.68
Resists	First :	15.49	Second :	16
Pivot price	15.11
Supports	First :	14.67	Second :	12.2
MAs	MA(5) :	14.79	MA(20) :	15.21
	MA(100) :	15.46	MA(250) :	14.85
MACD	MACD :	-0.3	Signal :	-0.2
%K %D	K(14,3) :	14.9	D(3) :	11.7
RSI	RSI(14): 38.7
52-week	High :	17.62	Low :	12

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ FONR ] has closed above bottom band by 21.6%. Bollinger Bands are 6.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	15.14 - 15.21	15.21 - 15.27
Low:	14.52 - 14.63	14.63 - 14.71
Close:	14.66 - 14.81	14.81 - 14.94

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.

Mon, 10 Nov 2025
FONAR Corporation Reports Q3 2025 Earnings - TipRanks

Mon, 10 Nov 2025
Fonar: Fiscal Q1 Earnings Snapshot - CTPost

Mon, 10 Nov 2025
FONAR CORP SEC 10-Q Report - TradingView

Mon, 10 Nov 2025
Fonar Announces Financial Results For The 1st Quarter of Fiscal 2026 - Newsfile

Thu, 06 Nov 2025
Price-Driven Insight from (FONR) for Rule-Based Strategy - news.stocktradersdaily.com

Thu, 11 Sep 2025
FONAR Announces Financial Results for Fiscal 2025 - Newsfile

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	6 (M)
Shares Float	6 (M)
Held by Insiders	4.6 (%)
Held by Institutions	47.3 (%)
Shares Short	39 (K)
Shares Short P.Month	59 (K)

EPS	1.23
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	27.4
Profit Margin	7.9 %
Operating Margin	3.2 %
Return on Assets (ttm)	3.3 %
Return on Equity (ttm)	6.7 %
Qtrly Rev. Growth	5 %
Gross Profit (p.s.)	6.95
Sales Per Share	16.91
EBITDA (p.s.)	2.58
Qtrly Earnings Growth	-10.4 %
Operating Cash Flow	11 (M)
Levered Free Cash Flow	3 (M)

PE Ratio	12.03
PEG Ratio	0
Price to Book value	0.53
Price to Sales	0.87
Price to Cash Flow	8.1

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.